https://www.deccanherald.com/business/union-budget/union-budget-2025-pharma-landscape-points-toward-need-to-focus-on-innovation-economic-survey-3382297
Exports accounted for 50 per cent of the total turnover, with its value at Rs 2.19 lakh crore in FY24. The total import of pharmaceuticals was worth Rs...
union budgetpharmalandscapepointstoward
https://www.pharmaceutical-technology.com/features/pharma-technology-focus-access-to-prep/
In this issue: PrEP access in England, taxing Big Pharma, treating endometriosis, and much more.
pharma technology focusaccesspreppharmaceutical
https://www.zeebiz.com/companies/news-ajanta-pharma-biocon-shares-in-focus-today-after-this-news-386410
Dec 24, 2025 - Mumbai-based Ajanta Pharma has entered into an agreement with Biocon to commercialise its version of semaglutide across select emerging markets. The...
ajanta pharmabioconsharesfocustoday
https://www.consorzionetcomm.it/eventi/netcomm-focus-digital-health-pharma-2025/
Dec 1, 2025 - La Trasformazione Digitale dei Pazienti, delle Farmacie e delle Filiere della SanitÃ
netcomm focusdigital healthamppharmaconsorzio
https://www.zeebiz.com/india/news-stocks-in-focus-on-september-26-pnb-gsk-pharma-and-hero-moto-here-are-5-newsmakers-of-the-day-111325
Indian stocks copied the weakness of the global equities - triggered by US Presidential impeachment bid - and closed in a red on Wednesday, but certain stocks...
gsk pharmastocksfocusseptemberpnb
https://www.timesnownews.com/videos/et-now/shows/nifty-50-slides-from-11-500-mark-pharma-stocks-steal-the-focus-buy-now-sell-now-sept/74576
The market started with a bit of momentum, by staying above the 11,500 mark, but the Nifty has slipped off from that mark. The sensex on the other hand is...
pharma stocksniftyslidesmarksteal
https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-23/
In this issue we look at new opportunities for the generics drug market, growing medicines in open fields, a new heuristic modelling system and much more
pharma technology focusissuepharmaceutical
https://www.businesstoday.in/markets/stocks/story/sun-pharma-shares-in-focus-on-dcgi-approval-for-generic-semaglutide-injection-512563-2026-01-23
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated for weight management as an adjunct to a reduced-calorie diet and increased...
sun pharmasharesfocusdcgiapproval